Practitioner Resources

Starvation, detoxification, and multi-drug resistance in cancer therapy.
The selection of chemotherapy drugs is based on the cytotoxicity to specific tumour cell types and the relatively low toxicity to normal cells and tissues. However, the toxicity to normal cells poses a major clinical challenge, particularly when malignant cells...
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression
short-term starvation (STS) protects normal cells while simultaneously sensitising malignant cells to high-dose chemotherapeutic drugs in mice and possibly patients. The fasting-dependent protection of normal cells and sensitisation of malignant cells depends, in part, on reduced levels of insulin-like growth...
Fasting enhances the response of glioma to chemo and radiotherapy
Glioma, including anaplastic astrocytoma and glioblastoma multiform (GBM) are among the most commonly diagnosed malignant adult brain tumours. GBM is a highly invasive and angiogenic tumour, resulting in a 12 to 15 months median survival. The treatment of GBM is...
Fasting vs. dietary restriction in cellular protection and cancer treatment: from model organisms to patients.
The dietary recommendation for cancer patients receiving chemotherapy, as described by the American Cancer Society, is to increase calorie and protein intake. Yet, in simple organisms, mice, and humans, fasting—no calorie intake—induces a wide range of changes associated with cellular...
Fasting Cycles Retard Growth of Tumours and Sensitise a Range of Cancer Cell Types to Chemotherapy.
Short-term starvation (or fasting) protects normal cells, mice, and potentially humans from the harmful side effects of a variety of chemotherapy drugs. Here we show that treatment with starvation conditions sensitised yeast cells (S. cerevisiae) expressing the oncogene-like RAS2val19 to...
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.
Mutations in growth signaling pathways extend life span, as well as protect against age-dependent DNA dam-age in yeast and decrease insulin resistance and cancer in mice. To test their effect in humans, we monitored for 22 years Ecuadorian individuals who...
Fasting and differential chemotherapy protection in patients.
Chronic calorie restriction retard cancer growth, but its weight-loss effect and the potential problems associated with combining it with chemotherapy have prevented its clinical application. Based on the discovery in model organ-isms that short term starvation (STS or fasting) causes...
Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
Inhibitors of the insulin-like growth factor-I (IGF-I) receptor have been widely studied for their ability to enhance the killing of a variety of malignant cells, but whether IGF-I signaling differentially protects the host and cancer cells against chemotherapy is unknown....
Periodic fasting starves cisplatin-resistant cancers to death
Treatment of cancers with the cytotoxic agent cisplatin frequently evokes resis-tance, accompanied by rewiring of meta-bolic pathways, limiting its clinical use. Recent research by Obrist et al (2018) shows that cisplatin-resistant growth of lung adenocarcinoma is particularly vulnerable to periodic...
Starvation, Stress Resistance, and Cancer
Cancer cells are characterized by dysregulation in signal transduction and metabolic pathways leading to increased glucose uptake, altered mitochon-drial function, and the evasion of antigrowth signals. Fasting and fasting-mimicking diets (FMDs) provide a particularly promising intervention to pro-mote differential effects...
Aging – Fasting and Cancer Treatment in Humans: A Case series report
Abstract: Short‐term fasting (48 hours) was shown to be effective  in protecting normal cells and mice but not cancer cells against  high  dose  chemotherapy,  termed  Differential  Stress  Resistance  (DSR),  but  the  feasibility  and  effect  of  fasting  in cancer  patients  undergoing ...
Can Fasting Blunt Chemotherapy’s Debilitating Side Effects?
Asking a cancer patient to fast while under-going chemotherapy may seem like adding insult to injury. But a dramatic experiment in mice has led some researchers to suggest that fasting may blunt the side effects of cancer treatment and perhaps...
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
Strategies to treat cancer have focused primarily on the killing of tumor cells. Here, we describe a differential stress resistance (DSR) method that focuses instead on protecting the organism but not cancer cells against chemotherapy. Download
Fasting and Cancer
Veronique Chachay, The University of Queensland The gold standard treatment for cancer in the last few decades has been a combination of surgery – to remove tumours – and chemotherapy and radiotherapy – to kill cancer cells. With the progress...
Prevention and treatment of cancer - interview with Prof Longo 2015
Valter Longo talks about his study of the positive effects of fasting, extreme diets and drugs that mimic them on the prevention and treatment of cancer. Recorded during the 1st Symposium IFOM-EMBL Monterotondo, June 2015